在I期临床试验中延迟毒性的分量累积无校准几率 (f-aCFO) 设计
1Department of Statistics and Actuarial Science, The University of Hong Kong, Hong Kong, China.
新的无校准累积赔率 (aCFO) 设计通过使用所有剂量信息来提高第一阶段试验的效率. 增强版本的TITE-aCFO和f-aCFO有效地管理晚发性毒性,提供强大的和用户友好的试验行为.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 药物指标 (Pharmacometrics) 是一个指标.
背景情况:
- 无校准赔率 (CFO) 设计是强大的,但与晚发性毒性作斗争.
- 现有的CFO方法使用有限的剂量信息,阻碍了数据的充分利用.
- 时间到事件 (TITE) 和分数方法解决了延迟的毒性,但可以改进.
研究的目的:
- 引入累积CFO (aCFO) 设计,以提高所有剂量级的信息利用率.
- 开发TITE-aCFO和f-aCFO设计,整合晚发性毒性数据.
- 评估aCFO及其变体与现有CFO设计的性能.
主要方法:
- 提出了aCFO设计,利用所有剂量水平的数据来改进决策.
- 在aCFO中整合了晚期发生的毒性,创建了TITE-aCFO和f-aCFO.
- 进行了广泛的模拟研究,以比较性能指标.
主要成果:
- 通过包含更广泛的剂量信息,aCFO设计表现出比原始CFO更好的性能.
- 在模拟中,f-aCFO设计表现出与现有方法相比更优异的性能.
- 在模拟的第一阶段试验中,aCFO和f-aCFO都表现出稳健性,效率和用户友好性.
结论:
- 通过使用全面的剂量信息,aCFO设计提高了I期试验的效率.
- TITE-aCFO和f-aCFO有效地应对与晚发性毒性相关的挑战.
- 这些先进的CFO设计为现代临床试验提供了强大,高效和实用的解决方案.
更多相关视频
10:33Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
Published on: September 4, 2017
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
相关概念视频
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Clinical Trials: Overview
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
